Issue details
Access to End of Life medicines
During the COVID 19 situation there is an
increased demand for access to End of Life medications. This paper
highlights changes made and other changes needing to be made to
meet the demand.
Decision type: Non-key
Decision status: Recommendations Approved
Notice of proposed decision first published: 20/04/2020
Decision due: 27 May 2020 by Executive Cabinet
Lead member: Executive Member for Adult Social Care and Population Health
Department: Commissioning
Agenda items
- 27/05/2020 - Strategic Commissioning Board Access to End of Life medicines 27/05/2020
Documents
- Access to End of Life medicines